SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-242437
Filing Date
2022-09-12
Accepted
2022-09-12 07:51:32
Documents
15
Period of Report
2022-09-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d323376d8k.htm   iXBRL 8-K 35747
2 EX-10.1 d323376dex101.htm EX-10.1 623164
3 EX-99.1 d323376dex991.htm EX-99.1 13006
7 GRAPHIC g323376g0912034310981.jpg GRAPHIC 3627
  Complete submission text file 0001193125-22-242437.txt   961579

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tcrx-20220912.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tcrx-20220912_lab.xml EX-101.LAB 17979
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tcrx-20220912_pre.xml EX-101.PRE 11255
9 EXTRACTED XBRL INSTANCE DOCUMENT d323376d8k_htm.xml XML 3351
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40603 | Film No.: 221237391
SIC: 2836 Biological Products, (No Diagnostic Substances)